Want to join the conversation?
$AGN said that excluding the FX impact and Namenda IR, all the therapeutic area of businesses delivered double-digit growth. Branded revenues grew double digit for the year. Nine of the top global products grew more than 15% for the year. The launch of LILETTA earlier this year has shown continued growth momentum in unit sales.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)